{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:32Z","timestamp":1792783052558,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-Level Local Universities in Shanghai","doi-asserted-by":"crossref","award":["SHSMU-ZDCX20210902"],"award-info":[{"award-number":["SHSMU-ZDCX20210902"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Science and Technology Commission of Shanghai","award":["20DZ2270800"],"award-info":[{"award-number":["20DZ2270800"]}]},{"name":"The Science and Technology Commission of Shanghai","award":["19JC1410200"],"award-info":[{"award-number":["19JC1410200"]}]},{"name":"the Project of Biobank of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["YBKA201907"],"award-info":[{"award-number":["YBKA201907"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Project of Biobank of Shanghai Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine","award":["YBKA202208"],"award-info":[{"award-number":["YBKA202208"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00277-023-05203-8","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:11:34Z","timestamp":1682075494000},"page":"2413-2423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma"],"prefix":"10.1007","volume":"102","author":[{"given":"Tianyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"5203_CR1","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/cancers14071742","volume":"14","author":"A Di Rocco","year":"2022","unstructured":"Di Rocco A, Petrucci L, Assanto GM, Martelli M, Pulsoni A (2022) Extranodal marginal zone lymphoma: pathogenesis, diagnosis and treatment. Cancers (Basel) 14:1742","journal-title":"Cancers (Basel)"},{"key":"5203_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pathol.2019.08.012","volume":"52","author":"S Nakamura","year":"2020","unstructured":"Nakamura S, Ponzoni M (2020) Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches. Pathology 52:15\u201329","journal-title":"Pathology"},{"key":"5203_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/aol-20-28","volume":"5","author":"JR Cerhan","year":"2021","unstructured":"Cerhan JR, Habermann TM (2021) Epidemiology of marginal zone lymphoma. Ann Lymphoma 5:1","journal-title":"Ann Lymphoma"},{"key":"5203_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic A, Lossos IS (2009) Extranodal marginal zone lymphoma of the ocular adnexa. Blood 114:501\u2013510","journal-title":"Blood"},{"key":"5203_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","volume":"31","author":"JA Ferry","year":"2007","unstructured":"Ferry JA et al (2007) Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 31:170\u2013184","journal-title":"Am J Surg Pathol"},{"key":"5203_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajh.10332","volume":"73","author":"EY Cho","year":"2003","unstructured":"Cho EY et al (2003) Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 73:87\u201396","journal-title":"Am J Hematol"},{"key":"5203_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/eye.2012.247","volume":"27","author":"SE Coupland","year":"2013","unstructured":"Coupland SE (2013) Molecular pathology of lymphoma. Eye (Lond) 27:180\u2013189","journal-title":"Eye (Lond)"},{"key":"5203_CR8","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1002\/cncr.11317","volume":"97","author":"C Wenzel","year":"2003","unstructured":"Wenzel C et al (2003) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 97:2236\u20132241","journal-title":"Cancer"},{"key":"5203_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.oraloncology.2007.11.011","volume":"44","author":"C Suh","year":"2008","unstructured":"Suh C, Huh J, Roh JL (2008) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence. Oral Oncol 44:949\u2013955","journal-title":"Oral Oncol"},{"key":"5203_CR10","doi-asserted-by":"publisher","unstructured":"Shi J et al. (2022) Predicting the risk of distant and local recurrence for patients with ocular adnexal extranodal marginal zone lymphoma: a matched case-control study. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjo-2022-321656","DOI":"10.1136\/bjo-2022-321656"},{"key":"5203_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/jjco\/hyz044","volume":"49","author":"J Lee","year":"2019","unstructured":"Lee J et al (2019) Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization. Jpn J Clin Oncol 49:664\u2013670","journal-title":"Jpn J Clin Oncol"},{"key":"5203_CR12","first-page":"3591","volume":"35","author":"S Ohga","year":"2015","unstructured":"Ohga S et al (2015) Treatment Outcome of Radiotherapy for Localized Primary Ocular Adnexal MALT Lymphoma-Prognostic effect of the AJCC tumor-node-metastasis clinical staging system. Anticancer Res 35:3591\u20133597","journal-title":"Anticancer Res"},{"key":"5203_CR13","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res 31:1860\u20131861","journal-title":"Cancer Res"},{"key":"5203_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-022-02445-8","volume":"41","author":"J Shi","year":"2022","unstructured":"Shi J et al (2022) Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker. J Exp Clin Cancer Res 41:234","journal-title":"J Exp Clin Cancer Res"},{"key":"5203_CR15","first-page":"199","volume":"1","author":"J Gerdes","year":"1990","unstructured":"Gerdes J (1990) Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1:199\u2013206","journal-title":"Semin Cancer Biol"},{"key":"5203_CR16","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1038\/sj.onc.1202750","volume":"18","author":"B L\u00fcscher","year":"1999","unstructured":"L\u00fcscher B, Larsson LG (1999) The basic region\/helix-loop-helix\/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 18:2955\u20132966","journal-title":"Oncogene"},{"key":"5203_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/bjh.14917","volume":"179","author":"M Schick","year":"2017","unstructured":"Schick M, Habringer S, Nilsson JA, Keller U (2017) Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers. Br J Haematol 179:724\u2013738","journal-title":"Br J Haematol"},{"key":"5203_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00109-016-1452-x","volume":"95","author":"X Lin","year":"2017","unstructured":"Lin X et al (2017) C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc\/snail\/Bax signaling. J Mol Med (Berl) 95:53\u201367","journal-title":"J Mol Med (Berl)"},{"key":"5203_CR19","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-10-3776","volume":"71","author":"A Wolfer","year":"2011","unstructured":"Wolfer A, Ramaswamy S (2011) MYC and metastasis. Cancer Res 71:2034\u20132037","journal-title":"Cancer Res"},{"key":"5203_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/genes8040116","volume":"8","author":"L Nguyen","year":"2017","unstructured":"Nguyen L, Papenhausen P, Shao H (2017) The role of c-MYC in B-cell lymphomas: diagnostic and molecular aspects. Genes (Basel) 8:116","journal-title":"Genes (Basel)"},{"key":"5203_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MCB.19.1.1","volume":"19","author":"CV Dang","year":"1999","unstructured":"Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1\u201311","journal-title":"Mol Cell Biol"},{"key":"5203_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2174\/157489206778776934","volume":"1","author":"S Robson","year":"2006","unstructured":"Robson S, Pelengaris S, Khan M (2006) c-Myc and downstream targets in the pathogenesis and treatment of cancer. Recent Pat Anticancer Drug Discov 1:305\u2013326","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"5203_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00432-009-0679-0","volume":"136","author":"K Komiya","year":"2010","unstructured":"Komiya K et al (2010) Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH\/3T3 cells. J Cancer Res Clin Oncol 136:465\u2013473","journal-title":"J Cancer Res Clin Oncol"},{"key":"5203_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.lungcan.2009.10.010","volume":"69","author":"K Komiya","year":"2010","unstructured":"Komiya K et al (2010) Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. Lung Cancer 69:232\u2013238","journal-title":"Lung Cancer"},{"key":"5203_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1440-1827.2007.02156.x","volume":"57","author":"H Ishizaki","year":"2007","unstructured":"Ishizaki H et al (2007) Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int 57:672\u2013680","journal-title":"Pathol Int"},{"key":"5203_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-021-03973-5","volume":"12","author":"P Xia","year":"2021","unstructured":"Xia P et al (2021) MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death Dis 12:691","journal-title":"Cell Death Dis"},{"key":"5203_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/01676830.2019.1704032","volume":"39","author":"OM Ahmed","year":"2020","unstructured":"Ahmed OM, Ma AK, Ahmed TM, Pointdujour-Lim R (2020) Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States. Orbit 39:397\u2013402","journal-title":"Orbit"},{"key":"5203_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajh.21406","volume":"84","author":"A Broyde","year":"2009","unstructured":"Broyde A et al (2009) Role and prognostic significance of the Ki-67 index in non-Hodgkin\u2019s lymphoma. Am J Hematol 84:338\u2013343","journal-title":"Am J Hematol"},{"key":"5203_CR29","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","volume":"34","author":"E Hoster","year":"2016","unstructured":"Hoster E et al (2016) Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the european mantle cell lymphoma network. J Clin Oncol 34:1386\u20131394","journal-title":"J Clin Oncol"},{"issue":"Pt A","key":"5203_CR30","first-page":"235","volume":"85","author":"R Bravo","year":"1982","unstructured":"Bravo R, Fey SJ, Bellatin J, Larsen PM, Celis JE (1982) Identification of a nuclear polypeptide (\u201ccyclin\u201d) whose relative proportion is sensitive to changes in the rate of cell proliferation and to transformation. Prog Clin Biol Res 85(Pt A):235\u2013248","journal-title":"Prog Clin Biol Res"},{"key":"5203_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/gut.50.3.290","volume":"50","author":"MR Alison","year":"2002","unstructured":"Alison MR, Hunt T, Forbes SJ (2002) Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 50:290\u2013291","journal-title":"Gut"},{"key":"5203_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1046\/j.1432-1033.2003.03440.x","volume":"270","author":"Y Ishimi","year":"2003","unstructured":"Ishimi Y et al (2003) Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix. Eur J Biochem 270:1089\u20131101","journal-title":"Eur J Biochem"},{"key":"5203_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/02688690120114174","volume":"16","author":"DP Hunt","year":"2002","unstructured":"Hunt DP et al (2002) Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein. Br J Neurosurg 16:10\u201315","journal-title":"Br J Neurosurg"},{"key":"5203_CR34","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1200\/JCO.2001.19.22.4259","volume":"19","author":"N Ramnath","year":"2001","unstructured":"Ramnath N et al (2001) MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol 19:4259\u20134266","journal-title":"J Clin Oncol"},{"key":"5203_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1034\/j.1600-0714.2003.00116.x","volume":"32","author":"I Kodani","year":"2003","unstructured":"Kodani I et al (2003) Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas. J Oral Pathol Med 32:468\u2013474","journal-title":"J Oral Pathol Med"},{"key":"5203_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/path.1625","volume":"204","author":"MA Gonzalez","year":"2004","unstructured":"Gonzalez MA et al (2004) Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 204:121\u2013130","journal-title":"J Pathol"},{"key":"5203_CR37","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/sj.bjc.6602795","volume":"93","author":"C Schrader","year":"2005","unstructured":"Schrader C et al (2005) Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br J Cancer 93:939\u2013945","journal-title":"Br J Cancer"},{"key":"5203_CR38","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2004-06-2297","volume":"105","author":"L Ho","year":"2005","unstructured":"Ho L et al (2005) MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 105:2891\u20132899","journal-title":"Blood"},{"key":"5203_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.20499","volume":"47","author":"K Honma","year":"2008","unstructured":"Honma K et al (2008) TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 47:1\u20137","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05203-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05203-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T08:07:57Z","timestamp":1692691677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05203-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5203"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05203-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research followed the tenets of the Declaration of Helsinki. The collection of the clinical and pathological information was approved by the institutional review board of Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (approval No. SH9H-2019T185-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}